This proof-of-concept study aimed to explore the association between galectin-3, pentraxin-3, systemic inflammatory markers, the severity of coronary stenosis, and AF burden in a cohort of patients with CCS and/or AF. The gene discussed is LGALS3; the disease is atrial fibrillation.